| Primary |
| Pneumonia Pneumococcal |
26.3% |
| Cellulitis |
10.5% |
| Convulsion |
10.5% |
| Infection |
10.5% |
| Influenza |
5.3% |
| Lower Respiratory Tract Infection |
5.3% |
| Otitis Externa |
5.3% |
| Prophylaxis |
5.3% |
| Scarlet Fever |
5.3% |
| Tonsillitis |
5.3% |
| Type 2 Diabetes Mellitus |
5.3% |
| Upper Respiratory Tract Infection |
5.3% |
|
| Drug Ineffective |
9.1% |
| Rash |
9.1% |
| Asphyxia |
4.5% |
| Dependence |
4.5% |
| Diarrhoea |
4.5% |
| Drug Intolerance |
4.5% |
| Hyperventilation |
4.5% |
| Loss Of Consciousness |
4.5% |
| Mental Status Changes |
4.5% |
| Myocardial Infarction |
4.5% |
| Nausea |
4.5% |
| Post-traumatic Stress Disorder |
4.5% |
| Pyrexia |
4.5% |
| Reaction To Colouring |
4.5% |
| Screaming |
4.5% |
| Somnolence |
4.5% |
| Swelling Face |
4.5% |
| Treatment Failure |
4.5% |
| Vasculitis Necrotising |
4.5% |
| Vomiting |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
50.7% |
| Drug Use For Unknown Indication |
10.7% |
| Convulsion |
6.6% |
| Tonsillitis |
5.9% |
| Acute Myeloid Leukaemia |
4.1% |
| Oropharyngeal Pain |
2.4% |
| Antibiotic Therapy |
1.7% |
| Atrial Fibrillation |
1.7% |
| Foetal Exposure During Pregnancy |
1.7% |
| Hiv Infection |
1.7% |
| Immunisation |
1.7% |
| Muscle Spasms |
1.7% |
| Influenza |
1.4% |
| Myelodysplastic Syndrome |
1.4% |
| Tracheitis |
1.4% |
| Anxiety |
1.0% |
| Back Pain |
1.0% |
| Dependence |
1.0% |
| Dysphagia |
1.0% |
| Erectile Dysfunction |
1.0% |
|
| Vomiting Projectile |
18.0% |
| Clostridium Difficile Infection |
9.8% |
| Gastroenteritis Viral |
9.8% |
| Diarrhoea |
8.2% |
| Thrombocytosis |
8.2% |
| Acute Myocardial Infarction |
6.6% |
| Platelet Count Increased |
4.9% |
| Therapeutic Response Decreased |
4.9% |
| Drug Interaction |
3.3% |
| Dyspnoea |
3.3% |
| Memory Impairment |
3.3% |
| Pulmonary Embolism |
3.3% |
| Skin Exfoliation |
3.3% |
| Vomiting |
3.3% |
| Agranulocytosis |
1.6% |
| Angioedema |
1.6% |
| Cerebrovascular Accident |
1.6% |
| Clostridium Difficile Colitis |
1.6% |
| Convulsion |
1.6% |
| Dental Discomfort |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
58.7% |
| Prophylaxis |
7.1% |
| Drug Use For Unknown Indication |
5.0% |
| Pain |
4.2% |
| Multiple Myeloma |
3.3% |
| B-cell Lymphoma |
2.4% |
| Pulmonary Embolism |
2.4% |
| Hypertension |
2.1% |
| Constipation |
1.9% |
| Chemotherapy |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Acute Myeloid Leukaemia |
1.4% |
| Epilepsy |
1.2% |
| Immunodeficiency |
1.2% |
| Pneumonia |
1.2% |
| Acute Myocardial Infarction |
0.9% |
| Bipolar Disorder |
0.9% |
| Cellulitis |
0.9% |
| Depression |
0.9% |
| Haemolytic Uraemic Syndrome |
0.9% |
|
| Swelling Face |
13.6% |
| Vomiting |
9.1% |
| Pulmonary Embolism |
7.6% |
| Dyspnoea |
6.1% |
| Pericardial Effusion |
6.1% |
| Meningococcal Infection |
4.5% |
| Pneumonia |
4.5% |
| Retroperitoneal Haemorrhage |
4.5% |
| Somnambulism |
4.5% |
| Thrombocytopenia |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Urticaria |
4.5% |
| Weight Increased |
4.5% |
| Amylase Increased |
3.0% |
| Drug Interaction |
3.0% |
| Drug Resistance |
3.0% |
| Erysipelas |
3.0% |
| Fluid Retention |
3.0% |
| Gastritis |
3.0% |
| Interstitial Lung Disease |
3.0% |
|
| Interacting |
| Atrial Fibrillation |
20.0% |
| Deep Vein Thrombosis |
20.0% |
| Hypercholesterolaemia |
20.0% |
| Infection |
20.0% |
| Pneumonia |
20.0% |
|
| International Normalised Ratio Increased |
50.0% |
| Therapeutic Response Decreased |
50.0% |
|
